Evaluating Retail and Mail Order Prescriptions

Each year Enlyte releases its drug trends series to analyze the state of pharmacy trends in workers' comp. In part one of our 2023 series, we’re evaluating retail and mail order prescriptions.

Infographic Summary

Drug costs have continued to fluctuate over the past several years. In 2023 eight of the top 10 classes were down, while two classes saw double-digit cost increases. Part 1 of our series uncovered prescribing patterns, including the largest drop in opioid utilization in recent years.

To view future installments of the drug trends series, be sure to visit our drug trends page.

Register to download the full content

  • This field is for validation purposes and should be left unchanged.


To learn more from Enlyte, please visit their website.

Enlyte is the parent brand of Mitchell | Genex | Coventry, a leader in cost-containment technology, independent medical exams (IME), provider and specialty networks, case management services, pharmacy benefit and disability management. The three businesses have recently aligned their joint industry expertise and advanced technology solutions into a combined organization of nearly 6,000 associates committed to simplifying and optimizing property, casualty and disability claims processes and services.

More from Risk & Insurance